Overview
Juncheng Dai practices practicing medicine in Nanjing, China.
Dai is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Stomach Cancer.
They are actively involved in clinical research, co-authoring 295 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Juncheng C. Dai
Is Juncheng C. Dai a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Juncheng C. Dai is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Juncheng C. Dai participate in research or clinical trials?
Yes. Juncheng C. Dai has published 295 articles and abstracts on conditions like Lung Cancer. You can view a list of Juncheng C. Dai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDai isDistinguished. Learn about Lung Cancer.
- Advanced
- Lung AdenocarcinomaDai isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Stomach CancerDai isAdvanced. Learn about Stomach Cancer.
- Experienced
- Acrofacial Dysostosis Rodriguez Type
- Acrofrontofacionasal Dysostosis Syndrome
- Adult Soft Tissue SarcomaDai isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerDai isExperienced. Learn about Anal Cancer.
- Bone TumorDai isExperienced. Learn about Bone Tumor.
- Breast CancerDai isExperienced. Learn about Breast Cancer.
- CalciphylaxisDai isExperienced. Learn about Calciphylaxis.
- Cervical CancerDai isExperienced. Learn about Cervical Cancer.
- Chronic Obstructive Pulmonary Disease (COPD)
- Colorectal CancerDai isExperienced. Learn about Colorectal Cancer.
- Congenital Heart Disease (CHD)
- Crouzon SyndromeDai isExperienced. Learn about Crouzon Syndrome.
- EGFR Positive Lung CancerDai isExperienced. Learn about EGFR Positive Lung Cancer.
- Esophageal CancerDai isExperienced. Learn about Esophageal Cancer.
- Goldenhar DiseaseDai isExperienced. Learn about Goldenhar Disease.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- HepatitisDai isExperienced. Learn about Hepatitis.
- Hepatitis BDai isExperienced. Learn about Hepatitis B.
- Liver CancerDai isExperienced. Learn about Liver Cancer.
- Lung MetastasesDai isExperienced. Learn about Lung Metastases.
- Marfan SyndromeDai isExperienced. Learn about Marfan Syndrome.
- Maturity Onset Diabetes of the Young
- ObesityDai isExperienced. Learn about Obesity.
- OsteosarcomaDai isExperienced. Learn about Osteosarcoma.
- Ovarian CarcinosarcomaDai isExperienced. Learn about Ovarian Carcinosarcoma.
- PIK3CA-Related Overgrowth Spectrum
- SilicosisDai isExperienced. Learn about Silicosis.
- Small Cell Lung Cancer (SCLC)
- Squamous Cell Lung Carcinoma
- Tetralogy of FallotDai isExperienced. Learn about Tetralogy of Fallot.
- Total Anomalous Pulmonary Venous Return
- Treacher Collins SyndromeDai isExperienced. Learn about Treacher Collins Syndrome.
- Triple-Negative Breast Cancer
- Turcot SyndromeDai isExperienced. Learn about Turcot Syndrome.
- Type 2 Diabetes (T2D)Dai isExperienced. Learn about Type 2 Diabetes (T2D).